EXPERIMENTAL TEST OF IN PRISON DRUG ABUSE TREATMENT

这项为期四年的研究将评估一种创新的 毒品治疗和艾滋病毒/艾滋病预防方案开始在 马萨诸塞州监狱由承包商频谱成瘾服务公司提供， Inc.州惩教部(DOC)和Spectrum 制定了创新的为期六个月的住宿计划，正在实施 在1993年秋季，将以统一的方式在6个月内交付 不同的设施。将优先治疗以下患者 被诊断为复发和/或再次犯罪的高风险。 这项研究将利用现有治疗方法的短缺。 相对于预期需求的空位进行对照实验。一个 据估计，目前在押的囚犯有7000人，至少三分之二 在每年2400多名新来的囚犯中，有吸毒史- 参与和虐待。该计划的容量将限制为 每年治疗约1100人。将这些稀缺的治疗分配给 老虎机，囚犯将接受筛查，接受治疗和游泳池 被确定为合适的罪犯将被挑选出来接受治疗 通过随机分配。这将产生两个种群，拥有700个 受试者每人：被分配到药物治疗项目的“实验者”， 和“控制”不是这样分配的。受试者将被给予基线 出狱后不久接受采访，并在四点重新接受采访 释放后12个月和9个月。治疗结果衡量标准 将包括复发到持续药物滥用的时间，另外， 实施犯罪的时间和恢复艾滋病毒风险的时间 行为。这些结果事件的指标将包括自我报告 复发、犯罪和艾滋病毒危险行为、尿检和官方 刑事司法记录。

This four-year study will evaluate treatment outcomes of an innovative drug treatment and HIV/AIDS prevention program begin implemented in the Massachusetts state prisons by a contractor, Spectrum Addiction Services, Inc. The state's Department of Correction (DOC) and Spectrum have developed an innovative six-month residential program, being implemented in the fall of 1993, that will be delivered in a uniform manner in six different facilities. Priority for treatment will be given to those diagnosed as being a high-risk of relapse and/or recidivism. The study will take advantage of the shortfall of available treatment slots relative to expected demand to conduct a controlled experiment. An estimated 7,000 prisoners currently in custody, and at least two-thirds of the 2,400-plus incoming prisoners each year, have histories of drug- involvement and abuse. The capacity of the program will be limited to treating approximately 1,100 per year. To allocate these scarce treatment slots, prisoners will be screened for admission to treatment and the pool of offenders identified as suitable will then be selected for treatment by random assignment. This will yield two populations, having 700 subjects each: "experimentals" assigned to the drug treatment program, and "controls" not so assigned. Subjects will be given baseline interviews shortly after release from prison, and reinterviewed at four months and twelve months following release. Treatment outcome measures will include time to relapse to sustained drug abuse and, separately, time to commission of a crime and time to resumption of HIV risk behavior. Indicators of these outcomes events will include self-reported relapse, criminality, and HIV-risk behaviors, urine tests, and official criminal justice records.